Abstract
Among the insights in commentaries to our article was the valuable suggestion that cryptomarkets serve a particular subpopulation of drug buyers; whatever harm-reducing outcomes they generate may simultaneously reproduce drug-related inequalities. We caution against generalising our arguments to other online purchasing locations and conclude that responses to cryptomarkets that do not acknowledge benefits may be short-sighted.
Original language | English |
---|---|
Journal | Addiction |
Early online date | 21 Feb 2018 |
DOIs |
|
Publication status | Published - 2018 |